Corporate digest
Add BT as a preferred sourceQT Vascular
QT Vascular and its chief executive officer Eitan Konstantino have successfully defended themselves against a patent infringement lawsuit filed by another medical firm, AngioScore, the Catalist-listed group said in a bourse filing on Wednesday. This means that it can continue to sell its "Chocolate PTA" balloon catheter without impediment, it added.
AngioScore, a specialty balloon angioplasty firm that was co-founded by Dr Konstantino, had claimed that Chocolate PTA infringed the "119 Patent" - a patent that claims a very specific design for an angioplasty balloon catheter and a non-deployable stent. However, QT Vascular said on Wednesday the jury's unanimous verdict "confirms that Chocolate is substantially different from the design disclosed in the '119 patent'".
Copyright SPH Media. All rights reserved.
